340B Contract Pharmacy Limits: The Conflict Continues - Life Sciences, Biotechnology & Nanotechnology
The first of three pending appeals on whether a pharmaceutical manufacturer can limit distribution of covered 340B drugs to contract pharmacies resulted in a clear victory for pharmaceutical manufacturers.
Source: mondaq.com